Therapeutic Plasma Exchange Shows Promise for Age-Related Disease Prevention

Therapeutic plasma exchange (TPE) represents a sophisticated blood purification technique that removes pathological plasma components while replacing them with healthy donor plasma or albumin solutions. This comprehensive review by researchers from City of Hope and collaborating institutions examines both established and emerging applications of TPE across multiple disease categories.

Currently, TPE serves as first-line therapy for life-threatening conditions like thrombotic thrombocytopenic purpura (TTP), where it removes large von Willebrand factor multimers and replaces deficient ADAMTS13 protease, reducing mortality from 90% to 20%. It's also established for neurological autoimmune conditions like Guillain-Barré syndrome and myasthenia gravis, where it removes pathogenic autoantibodies and immune complexes.

The review highlights TPE's underexplored potential in preventative medicine for age-related diseases. Emerging applications include cardiovascular disease prevention through removal of inflammatory cytokines and oxidized lipoproteins, metabolic disorder management by clearing insulin resistance factors, and neurodegeneration treatment by eliminating toxic protein aggregates and inflammatory mediators. Recent studies suggest TPE may benefit Alzheimer's disease patients by removing amyloid-beta and tau proteins from circulation.

The authors emphasize TPE's unique ability to target extracellular vesicles (EVs) that carry disease-promoting signals between cells. These vesicles play crucial roles in inflammation, cancer metastasis, and tissue aging. By removing pathological EVs while potentially infusing beneficial ones, TPE could modulate cellular communication networks throughout the body.

Future TPE applications may involve personalized approaches using multi-omic plasma diagnostics to identify individual disease signatures, followed by targeted removal of specific pathological factors. The authors envision combining TPE with therapeutic plasma infusions containing beneficial factors like growth factors, anti-inflammatory molecules, or young plasma components to actively promote tissue rejuvenation rather than simply removing harmful substances.